0000905718-18-000368.txt : 20180405 0000905718-18-000368.hdr.sgml : 20180405 20180405103840 ACCESSION NUMBER: 0000905718-18-000368 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180405 DATE AS OF CHANGE: 20180405 EFFECTIVENESS DATE: 20180405 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Virpax Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001708331 IRS NUMBER: 821510982 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-309394 FILM NUMBER: 18739605 BUSINESS ADDRESS: STREET 1: 101 LINDENWOOD DR., SUITE 225 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484-875-3195 MAIL ADDRESS: STREET 1: 101 LINDENWOOD DR., SUITE 225 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Virpax Pharmaceuticals Inc. DATE OF NAME CHANGE: 20170602 D 1 primary_doc.xml X0708 D LIVE 0001708331 Virpax Pharmaceuticals, Inc. 101 LINDENWOOD DR. SUITE 225 MALVERN PA PENNSYLVANIA 19355 561-362-9595 DELAWARE None Virpax Pharmaceuticals Inc. Corporation true 2017 Anthony Mack c/o Virpax Pharmaceuticals, Inc. 101 Lindenwood Drive, Suite 225 Malvern PA PENNSYLVANIA 19355 Executive Officer Director Jeffrey Gudin c/o Virpax Pharmaceuticals, Inc. 101 Lindenwood Drive, Suite 225 Malvern PA PENNSYLVANIA 19355 Executive Officer Director Eric Floyd c/o Virpax Pharmaceuticals, Inc. 101 Lindenwood Drive, Suite 225 Malvern PA PENNSYLVANIA 19355 Director Jerrold Sendrow c/o Virpax Pharmaceuticals, Inc. 101 Lindenwood Drive, Suite 225 Malvern PA PENNSYLVANIA 19355 Director Thani Jambulingam c/o Virpax Pharmaceuticals, Inc. 101 Lindenwood Drive, Suite 225 Malvern PA PENNSYLVANIA 19355 Director Pharmaceuticals Decline to Disclose 06b false 2018-02-08 false true false 0 3000000 1379000 1621000 Includes the conversion of certain indebtedness false 8 0 0 0 true Some of the proceeds may be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3. false Virpax Pharmaceuticals, Inc. /s/ Anthony Mack Anthony Mack Chief Executive Officer 2018-04-05